The war on cancer occurs at the bench and in the clinic, but the scientists fighting these battles must first be trained in classroom, laboratory, and clinical settings. As much as anything, training the next generation of cancer researchers is critical to reducing the heavy burden of a cancer diagnosis.

There are a wide variety of undergraduate, pre- and post-doctoral training opportunities available in the laboratories of Huntsman Cancer Institute members. These training opportunities encompass basic science discovery, clinical investigation and population-based studies. Our goals are to understand cancer from its beginnings, to use this knowledge to create new and better treatments, to implement these strategies to improve outcomes and to learn from our efforts across populations to continually minimize the burdens of cancer.

Trainees flourish in a collaborative and collegial, multidisciplinary research environment under the guidance of experienced mentors. Currently, 136 cancer center members, spanning 27 academic departments, mentor 362 trainees in state-of-the-art research facilities.

HCI 2016-2017 Seminar Series

Recent News

Press Releases, HCI News

Grand Valley Oncology Announces Clinical Trials Open to Patients

Mesa County, Colo.--- Grand Valley Oncology with the support of Huntsman Cancer Institute (HCI) at the University of Utah will offer a range of clinical trials for their patients. Physicians at Grand Junction Oncology will work closely with their counterparts at HCI to identify opportunities for patients in western Colorado to participate in clinical trials.

Read More

HCI News, Press Releases

New Cancer Drug Tested In Mice May Benefit Certain Leukemia Patients

SALT LAKE CITY –Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults. Scientists have found up to 30 percent of adult ALL patients have what’s called a Philadelphia chromosome, where two segments of chromosomes have aberrantly fused together. (The fusion chromosome is much less common in children.) Adult ALL patients exposed to standard treatments often see high relapse rates, and treatment-related deaths remain high. But researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered new science, published this week in the journal Leukemia, that could provide better therapeutic options for patients.

Read More

HCI News, Press Releases

Huntsman Cancer Institute at the University of Utah Selected to Join National Cancer Institute’s Systems Biology Consortium

SALT LAKE CITY – Huntsman Cancer Institute (HCI) and the College of Pharmacy at the University of Utah (U of U) have been awarded a $9.1 million, five-year grant from the National Cancer Institute (NCI) to serve as a Research Center in NCI’s Cancer Systems Biology Consortium (CSBC). HCI is one of nine research institutions nationwide to be selected as a Research Center in the CSBC.

Read More